In 1994, Johnson & Johnson started selling an anti-psychotic drug called Risperdal. The FDA approved it for adults with schizophrenia, but it expressly forbade Johnson & Johnson from marketing Risperdal to treat children and the elderly—there were too many dangerous side effects. Nevertheless, for more than a decade, that’s exactly what Johnson & Johnson did. And despite government sanctions for its behavior, and thousands of lawsuits, the company made billions in profits.
Photo by Housed
